Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Paul Van Schil MD, PhD

Paul EY Van Schil MD, PhD

Professor in Thoracic and Vascular Surgery at the Faculty of Medicine, member of the Antwerp Surgical Training and Research Center (ASTARC); consultant at the Department of Thoracic and Vascular Surgery of the Antwerp University Hospital, Antwerp, Belgium

Paul Van Schil was born on July 7, 1957 in Antwerp, Belgium. He graduated from medical school with great honour in 1982 at the Antwerp University in Belgium. After completing his training in general surgery, he became a fellow in the department of cardiothoracic surgery at the Antonius Hospital, Nieuwegein, the Netherlands. His doctoral thesis was entitled “Bronchial sleeve resection for lung cancer: long-term results” (University of Nijmegen, the Netherlands, 1992).  

In 1990 he became a staff member at the department of surgery of the Antwerp University Hospital. Currently, he is professor in thoracic and vascular surgery at the Faculty of Medicine, member of the Antwerp Surgical Training and Research Center (ASTARC) and consultant at the department of thoracic and vascular surgery of the Antwerp University Hospital.  

From October 2013 till October 2014 he was president of the European Association for Cardio-thoracic Surgery (EACTS).  In 2017 he became member of Board of Directors of the International Association for the Study of Lung Cancer (IASLC) and chair of the lung cancer domain of its Staging and Prognostic Factors Committee (SPFC). Currently, he is an associate editor of the European Respiratory Journal, Journal of Thoracic Oncology and Acta Chirurgica Belgica. His main interests are thoracic and vascular surgery with a special emphasis on lung cancer staging and therapy, lung metastases and mesothelioma.


Relevant disclosures:

- external expert MSD, Astra Zeneca and National Cancer Institute (France) – institutional fees only.